State of the art of leadless pacing

Despite undisputable benefits, conventional pacemaker therapy is associated with specific complications related to the subcutaneous device and the transvenous leads. Recently, two miniaturized leadless pacemakers, Nanostim™ (St. Jude Medical) and Micra™ (Medtronic), which can be completely implanted inside the right ventricle using steerable delivery systems, entered clinical application. The WiCS™-cardiac resynchronisation therapy (CRT) system (wireless cardiac stimulation for CRT, EBR Systems) delivers leadless left ventricular endocardial stimulation for cardiac resynchronization. In addition to obvious cosmetic benefits, leadless pacing systems may have the potential to overcome some complications of conventional pacing. However, acute and long-term complications still remains to be determined, as well as the feasibility of device explantation years after device placement.

[1]  David A. Kass,et al.  Optimal left ventricular endocardial pacing sites for cardiac resynchronization therapy in patients with ischemic cardiomyopathy. , 2010, Journal of the American College of Cardiology.

[2]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[3]  Michael Eggen,et al.  Early Performance and Safety of the Micra Transcatheter Pacemaker in Pigs , 2015, Pacing and clinical electrophysiology : PACE.

[4]  M. Scheffer,et al.  Transseptal endocardial left ventricular pacing: an alternative technique for coronary sinus lead placement in cardiac resynchronization therapy. , 2007, Heart rhythm.

[5]  J. Daubert,et al.  Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[7]  Hung-Fat Tse,et al.  First human demonstration of cardiac stimulation with transcutaneous ultrasound energy delivery: implications for wireless pacing with implantable devices. , 2007, Journal of the American College of Cardiology.

[8]  P. Neužil,et al.  Implantable intravascular defibrillator: defibrillation thresholds of an intravascular cardioverter-defibrillator compared with those of a conventional ICD in humans. , 2014, Heart rhythm.

[9]  Angelo Auricchio,et al.  Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  R. Erbel,et al.  Leadless Pacing of the Heart Using Induction Technology: A Feasibility Study , 2009, Pacing and clinical electrophysiology : PACE.

[11]  Ellen Aagaard Nohr,et al.  Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark , 2013, European heart journal.

[12]  P. Brink,et al.  Stem cell-based biological pacemakers from proof of principle to therapy: a review. , 2014, Cytotherapy.

[13]  Arthur A M Wilde,et al.  Permanent Leadless Cardiac Pacing: Results of the LEADLESS Trial , 2014, Circulation.

[14]  R. E. Riley,et al.  Feasibility and safety of a novel technology for pacing without leads. , 2006, Heart rhythm.

[15]  John L Sapp,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[16]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[17]  D. Shah,et al.  Comparison of chronic biventricular pacing between epicardial and endocardial left ventricular stimulation using Doppler tissue imaging in patients with heart failure. , 2001, The American journal of cardiology.

[18]  T. Betts,et al.  Development of a Technique for Left Ventricular Endocardial Pacing via Puncture of the Interventricular Septum , 2014, Circulation. Arrhythmia and electrophysiology.

[19]  E. Foster,et al.  Clinical factors and echocardiographic techniques related to the presence, size, and location of acoustic windows for leadless cardiac pacing. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[20]  C. Tsagarakis,et al.  A Miniature Pacemaker Introduced Intravenously and Implanted Endocardially. Preliminary Findings from an Experimental Study , 1991 .

[21]  M. Haissaguerre,et al.  Left ventricular endocardial stimulation for severe heart failure. , 2010, Journal of the American College of Cardiology.

[22]  C. Leclercq,et al.  Left ventricular endocardial or triventricular pacing to optimize cardiac resynchronization therapy in a chronic canine model of ischemic heart failure. , 2012, American journal of physiology. Heart and circulatory physiology.

[23]  J. W. Spickler,et al.  Totally self-contained intracardiac pacemaker. , 1970, Journal of electrocardiology.